Accuray, Inc. is a radiation therapy company, which engages in manufacturing medical equipment. The company is headquartered in Madison, Wisconsin. The company went IPO on 2007-02-08. The firm develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.
Follow-Up Questions
Who is the CEO of Accuray Inc?
Ms. Suzanne Winter is the President of Accuray Inc, joining the firm since 2019.
What is the price performance of ARAY stock?
The current price of ARAY is $1.73, it has increased 2.36% in the last trading day.
What are the primary business themes or industries for Accuray Inc?
Accuray Inc belongs to Health Care industry and the sector is Health Care
What is Accuray Inc market cap?
Accuray Inc's current market cap is $194.9M
Is Accuray Inc a buy, sell, or hold?
According to wall street analysts, 5 analysts have made analyst ratings for Accuray Inc, including 4 strong buy, 5 buy, 1 hold, 0 sell, and 4 strong sell
